MIRABEL, Quebec, July 14, 2020 /PRNewswire/ -- i3 BioMedical
Inc. today announced that a team of scientists at the University of Toronto tested and established that
the virus SARS-CoV-2, which causes Covid-19, cannot be recovered
after being applied to the TrioMed Active mask. The mask's external
surface deactivates >99% of the Coronavirus suspension within
minutes.
The TrioMed Active Mask type IIR surgical mask incorporates
TrioMed's technology and provides an advanced level of active
protection for healthcare workers and the general population. The
patented antimicrobial technology is at the core of the company's
entire line of medical products such as wound dressings, medical
tapes, gloves, headwear, gowns and other personal protective
equipment sold globally.
A study published in the American Journal of Infection Control
established that people touch their face 23 times per hour on
average1. Furthermore, the coronavirus that causes
Covid-19 remains present and infectious on the outer layer of masks
for up to 7 days, according to a study published in The Lancet
Microbe2. In addition to the warnings issued by
governmental authorities pertaining to self-contamination by
touching one's mask, these two scientific publications further
demonstrate the major deficiency in the level of protection for all
wearers of current masks.
"The TrioMed Active Mask is the first and only respiratory
protection that is scientifically proven to deactivate the virus
causing Covid-19, therefore drastically reducing the risk of
contamination for the wearer", says Pierre
Jean Messier, founder and CEO of i3 Biomedical Inc. "Our
company spent years and millions of dollars to develop this
interactive antimicrobial technology. The resulting products are
used by the medical community around the world and have been tested
by independent laboratories to kill numerous microbes, such as
MRSA, VRE, E-Coli, Staphylococcus Aureus, Influenza Virus and now
SARS-CoV-2. This third-party scientific testing confirms TrioMed's
leading position in medical antimicrobial technology available in
the global fight against Covid-19."
Features and benefits of the TrioMed Active mask include:
- Active antimicrobial protection of the mask outer layer
deactivates >99% of the Coronavirus SARS 2 and Influenza virus
H1N1
- Viral filtration efficiency (VFE) > 99.9%
- Bacterial filtration efficiency (BFE) > 99.9%
- Meets ASTM F2100 Level 3
- Meets European Medical Device standard EN 14683 Type IIR
- Five-year shelf life
About i3 BioMedical Inc: i3 BioMedical is a Canadian
company, focused on the development and manufacturing of novel
antimicrobial products that help prevent the spread of infection
and disease.
___________________________________
|
1
|
Kwok YL, Gralton J,
McLaws ML. Face touching: a frequent habit that has implications
for hand hygiene. Am J Infect Control.
2015;43(2):112-114. doi:10.1016/j.ajic.2014.10.015
|
2
|
Chin A W H, Chu J T
S, Perera M R A, et al. Stability of SARS-CoV-2 in different
environmental conditions. Lancet Microbe 2020; published online
April 2. https://doi.org/10.1016/S2666-5247(20)30003-3.
|
For more information on the TrioMed Active face masks, visit
www.triomed.com or send an email to triomed@triomed.com;
media.relations@utoronto.ca
Photo -
https://mma.prnewswire.com/media/1213779/I3_BioMedical_Inc__University_of_Toronto_Tests_Confirm_First_Mas.jpg